View in EDS HTML Full Text PDF Full Text

Use of recombinant factor VIIa (NovoSeven®®) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux.

Saved in:
Bibliographic Details
Title: Use of recombinant factor VIIa (NovoSeven®®) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux.
Authors: Luporsi, P.1 (AUTHOR), Chopard, R.1 (AUTHOR), Janin, S.1 (AUTHOR), Racadot, E.1 (AUTHOR), Bernard, Y.1 (AUTHOR), Ecarnot, F.1 (AUTHOR), Séronde, MF.1 (AUTHOR), Briand, F.1 (AUTHOR), Guignier, A.1 (AUTHOR), Descotes-Genon, V.1 (AUTHOR), Meneveau, N.1 (AUTHOR), Schiele, F.1 (AUTHOR) francois.schiele@univ-fcomte.fr
Source: Acute Cardiac Care. Jul2011, Vol. 13 Issue 2, p93-98. 6p. 3 Charts, 3 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17482941
DOI:10.3109/17482941.2011.567281